Valuation: ArcticZymes Technologies ASA

Market Cap 1.01B 104M 91.13M 84.86M 78.05M 146M 9.92B 149M 1.01B 394M 4.92B 390M 381M 17B P/E 2026 *
56.2x
P/E 2027 * 31.2x
Enterprise Value 728M 75.16M 65.96M 61.42M 56.5M 106M 7.18B 108M 729M 285M 3.56B 282M 276M 12.3B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.29x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 week+0.77%
Current month-1.99%
1 month-1.50%
3 months-5.29%
6 months-11.66%
Current year-4.37%
1 week 19
Extreme 19
20.2
1 month 18.35
Extreme 18.35
20.9
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
108.3
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 2023-09-17
Director of Finance/CFO 51 2014-09-30
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 2024-06-25
Director/Board Member 62 2024-06-25
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
8/14/25 Buy

Director

2,852 0.0056%
6/4/25 Buy

Chief Operating Officer

3,400 0.0067%
5/14/25 Fiscal year

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.77%+6.49%-48.50% 104M
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
+2.17%+10.22%+41.17%+36.56% 359B
+1.46%+3.87%+39.70%+44.49% 303B
+0.40%+3.59%+19.93%+17.02% 267B
+2.73%+3.50%-25.66%-36.53% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +1.96%+4.64%+28.21%+44.77% 373.12B
Weighted average by Cap. +1.97%+5.14%+39.89%+80.14%

Financials

2026 *2027 *
Net sales 137M 14.13M 12.4M 11.55M 10.62M 19.91M 1.35B 20.25M 137M 53.62M 669M 53.04M 51.9M 2.31B 162M 16.72M 14.68M 13.67M 12.57M 23.56M 1.6B 23.97M 162M 63.46M 792M 62.78M 61.43M 2.74B
Net income 18.1M 1.87M 1.64M 1.53M 1.4M 2.63M 178M 2.68M 18.11M 7.09M 88.51M 7.01M 6.86M 306M 32.58M 3.36M 2.95M 2.75M 2.53M 4.74M 321M 4.82M 32.6M 12.76M 159M 12.62M 12.35M 550M
Net Debt -278M -28.67M -25.16M -23.43M -21.55M -40.4M -2.74B -41.1M -278M -109M -1.36B -108M -105M -4.69B -310M -32.03M -28.11M -26.18M -24.08M -45.13M -3.06B -45.91M -311M -122M -1.52B -120M -118M -5.24B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26-07-28 NOK 19.70 0.00% 13,720
26-07-27 NOK 19.70 +1.29% 8,197
26-07-24 NOK 19.45 -3.23% 9,101
26-07-23 NOK 20.10 +1.52% 10,725
26-07-22 NOK 19.80 +1.28% 8,269
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.70NOK
Average target price
31.00NOK
Spread / Average Target
+57.36%

Quarterly revenue - Rate of surprise